Amy Clack executes 10b5-1 sale of 1,677 shares (TW)
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
Issuer Form 144 shows a planned sale by Amy Clack via a 10b5-1 plan. The filing lists a sale of 1,677 shares of Common Stock on 02/10/2026 for $192,318.36. The filing also lists 271 Restricted Stock Units tied to 03/17/2026.
Positive
- None.
Negative
- None.
Insights
Insider executed a planned 10b5-1 disposition; magnitude is modest.
The filing records a 10b5-1 sale by Amy Clack of 1,677 shares on 02/10/2026 with proceeds of $192,318.36. The reported amount is a specific, executed disposition under a pre-arranged plan.
Filing also lists 271 Restricted Stock Units associated with 03/17/2026. Cash‑flow treatment and whether the RSUs represent an additional market sale are not detailed in the provided excerpt; subsequent reports would clarify execution or settlement details.
FAQ
What did Amy Clack report in the Form 144 for TW?
Amy Clack reported a 10b5-1 sale of 1,677 shares of Common Stock on 02/10/2026, yielding $192,318.36. The filing also lists 271 Restricted Stock Units dated 03/17/2026.
Does the Form 144 for TW list any Restricted Stock Units?
Yes. The excerpt lists 271 Restricted Stock Units associated with 03/17/2026. The filing identifies the instrument and date but does not detail settlement mechanics in the provided text.
Was the sale by Amy Clack an open‑market trade or pre‑arranged?
The sale is described as a 10b5-1 sale, indicating it was executed pursuant to a pre-arranged plan. The excerpt explicitly labels the transaction as a 10b5-1 sale on 02/10/2026.